Tctex-1 Regulatory Sequence for Neural Progenitor Cell Marking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating neural progenitor cells from the adult hippocampus lack tissue specificity, making it difficult to selectively manipulate and study these cells for therapeutic and research purposes.
Innovation Solution
The use of a specific genomic sequence for Tctex-1, which is transcriptionally active in neural progenitor cells, allows for the selective expression of markers or effector sequences in these cells, enabling their marking, harvesting, and assessment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If regulatory sequences such as Tα-tubulin promoter or GFAP promoter are used to target neural progenitor cells, then some neural cell types can be marked, but tissue-specificity is poor and off-target labeling occurs in neurons or astroglials
Solution Approach 1:
The patent applies local quality by identifying and utilizing a specific regulatory sequence (Tctex-1 promoter) that is locally active only in neural progenitor cells at the subgranular zone of the dentate gyrus. This sequence exhibits distinct transcriptional activity compared to other neural cell types, enabling selective marking of progenitors without labeling neurons or astroglials, thus resolving the tissue-specificity issue.
Solution Approach 2:
The patent uses a reporter gene construct where the Tctex-1 regulatory sequence is coupled with a detectable marker (such as GFP or LacZ). This copying approach allows the regulatory sequence to be visualized and validated in transgenic animals, confirming its cell-type-specific activity and proving its utility for selective marking without requiring direct manipulation of the endogenous Tctex-1 gene.
2Adaptability or versatility
If adult stem cells are used for research and therapy, then ethical questions are avoided, but the cells are difficult to selectively isolate and manipulate due to lack of specific markers
Solution Approach 1:
The patent performs preliminary action by introducing the Tctex-1 regulatory sequence coupled with a reporter gene into adult neural progenitor cells before any manipulation or therapy is attempted. This preliminary genetic marking enables subsequent easy identification, isolation, and manipulation of these cells using standard molecular biology techniques, thereby facilitating both research and therapeutic applications.
Solution Approach 2:
The patent employs a reporter gene (such as GFP or LacZ) as an intermediary marker that is driven by the Tctex-1 regulatory sequence. This intermediary allows indirect visualization and selection of neural progenitor cells through fluorescent or enzymatic signals, making the cells accessible for manipulation while maintaining their biological identity and therapeutic potential.
3Reliability
If neural progenitor cells are to be manipulated for disease treatment, then therapeutic strategies can be developed, but current methods lack the precision to ensure high purity of isolated cell populations
Solution Approach 1:
The patent utilizes color changes through fluorescent reporter genes (such as GFP - green fluorescent protein) that are expressed under the control of the Tctex-1 regulatory sequence. This allows neural progenitor cells to be visually distinguished from other cell types in the brain, enabling precise isolation techniques such as fluorescence-activated cell sorting (FACS) to obtain high-purity cell populations with minimal contamination.
Data Source
AI summary
The disclosure relates to an isolated regulatory sequence for Tctex-1 that is transcriptionally active in adult neural progenitor and stem cells, including Type 1, Type 2 and Type 3 progenitors, as well as during development. The disclosure also relates to a method for selectively expressing a genetic sequence in neural progenitor cells. The disclosure of inserting and expressing a specific sequence in these cells allows marking, identification, sorting, tracking, and manipulating neural progenitor and stem cells.